We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Industry Comment on Guidance on Liver Injury
FDA Seeks Industry Comment on Guidance on Liver Injury
April 14, 2010
Sponsors are being asked to comment on a guidance issued last year on drug-induced liver injury (DILI) as the FDA recognizes that the guidance will not
be the last word on this common adverse event.